Biochemistry
-
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
This article has 11 authors:Reviewed by ScreenIT
-
Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain
This article has 17 authors:Reviewed by ScreenIT
-
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
This article has 25 authors:Reviewed by ScreenIT
-
The crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine
This article has 14 authors:Reviewed by ScreenIT
-
Sybodies targeting the SARS-CoV-2 receptor-binding domain
This article has 13 authors:Reviewed by ScreenIT
-
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
This article has 5 authors:Reviewed by ScreenIT
-
Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry
This article has 11 authors:Reviewed by ScreenIT
-
De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to aid drug discovery
This article has 9 authors:Reviewed by ScreenIT
-
Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence
This article has 1 author:Reviewed by ScreenIT
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
This article has 21 authors:Reviewed by ScreenIT